Arzerra Injection
Marketer
Glaxo SmithKline Pharmaceuticals Ltd
Salt Composition
Ofatumumab (100mg/5ml)
Overview Arzerra Injection
Obinutuzumab (Arzerra) is indicated for treating chronic lymphocytic leukemia (CLL), a type of blood cancer. Its mechanism involves targeting receptors on cancerous blood cells, marking them for elimination by the patient's immune system. Arzerra is administered intravenously under strict medical supervision. Dosage and frequency are determined by your physician based on your individual needs and may vary over the course of treatment. Adhere precisely to your doctor's prescribed regimen; incorrect usage or overdose can lead to severe adverse effects. While therapeutic benefits may not be immediately apparent (requiring weeks or months), discontinue use only upon your doctor's instruction. Common side effects include nausea, diarrhea, dyspnea, and cough. Report any persistent or bothersome side effects to your healthcare provider promptly. Regular blood tests are crucial to monitor blood counts, as well as hepatic, renal, and cardiac function. Prior to initiating treatment, inform your physician of any pre-existing cardiac, hepatic, or renal conditions, and all medications (including anti-infectives) you are currently taking. Significant drug interactions are possible, so comprehensive disclosure of all medications is essential. Arzerra is contraindicated during pregnancy and breastfeeding; reliable contraception is mandatory for both partners throughout the treatment period.
Uses of Arzerra Injection
Chronic lymphocytic leukemia, a type of blood malignancy.
Major Benefits of Arzerra Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Arzerra Injection:
- Nausea
- Diarrhea
- Breathlessness
- Cough
- Flushing of skin
- Low energy
- Skin rash
How to use Arzerra Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Arzerra Injection works:
Ofatumumab injection, a monoclonal antibody, targets specific receptors on malignant cells, marking them for elimination by the patient's own immune defenses.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Arzerra Injection may pose unknown risks. Seek your physician's advice.
PregnancyCONSULT YOUR DOCTOR
The use of Arzerra Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice from your doctor.
Breast feedingSAFE IF PRESCRIBED
Breastfeeding mothers can likely use Arzerra Injection safely. Available data from humans indicate minimal infant risk associated with the medication.
DrivingCONSULT YOUR DOCTOR
Arzerra Injection's effect on driving ability is unknown. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Ofatumumab injection poses no safety concerns for patients with renal impairment; no dosage modification is advised.
LiverUNSAFE
Patients with liver conditions should likely refrain from Arzerra Injection due to potential safety concerns. Physician consultation is recommended.
What if you forget to take Arzerra Injection :
NA
Facts to Know About Arzerra Injection
| Label | Value |
|---|---|
| Chemical Type | Monoclonal antibody |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Action Class | Anti-CD20 Antibody |
3,018 People bought this recently